Radiologists can now charge Medicare for MRIs when the patient has a pacemarker approved for MRI exams.
The Centers for Medicare & Medicaid Services (CMS) has expanded coverage to include MRI for beneficiaries with implanted pacemakers when used according to FDA-approved labeling in an MRI environment.
A final National Coverage Determination posted today provides access to the MRI environment for patients with FDA-approved pacemakers.
On February 8, the FDA approved the RevoMRI SureScan Pacing System, which is designed for use in the MRI environment for certain MRI exams. Currently, there are no other pacemakers or implantable cardioverter defibrillators that are FDA-approved for use in the MRI environment.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.